miR-526b-3p serves as a prognostic factor and regulates the proliferation, invasion, and migration of glioma through targeting WEE1

References

• Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics. CA Cancer J Clin. 2016;66(4):271–289. doi:10.3322/caac.2134927253694
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.2133826808342
   PubMed Web of Science ®Google Scholar
• Jiang T, Mao Y, Ma W, et al. Chinese Glioma Cooperative Group (CGCG). CGCG clinical practice guidelines for the management of adult diffuse gliomas. Cancer Lett. 2016 Jun 1;375(2):263–273.
   Google Scholar
• Champ CE, Palmer JD, Volek JS, et al. Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme. J Neurooncol. 2014;117(1):125–131. doi:10.1007/s11060-014-1362-024442482
   PubMed Web of Science ®Google Scholar
• Ikeda H, Shiku H Antigen-receptor gene-modified T cells for treatment of glioma. Adv Exp Med Biol. 2012;746:202–215. doi:10.1007/978-1-4614-3146-6_1622639170
   PubMed Web of Science ®Google Scholar
• Kang JH, Adamson C Novel chemotherapeutics and other therapies for treating high-grade glioma. Expert Opin Investig Drugs. 2015;24(10):1361–1379. doi:10.1517/13543784.2015.1048332
   PubMed Web of Science ®Google Scholar
• Hammond SM An overview of microRNAs. Adv Drug Deliv Rev. 2015;87:3–14. doi:10.1016/j.addr.2015.05.00125979468
   PubMed Web of Science ®Google Scholar
• Bak RO, Mikkelsen JG miRNA sponges: soaking up miRNAs for regulation of gene expression. Wiley Interdiscip Rev RNA. 2014;5(3):317–333. doi:10.1002/wrna.121324375960
   PubMed Web of Science ®Google Scholar
• Sand M The pathway of miRNA maturation. Methods Mol Biol. 2014;1095:3–10. doi:10.1007/978-1-62703-703-7_124166299
   PubMedGoogle Scholar
• Gao Y, Lin L, Lin T, et al. The role of miRNA-233 in cancer: Function, diagnosis and therapy. Gene. 2017 Jun 15;616:1–7.
   Google Scholar
• Li J, Chen Y, Guo X, et al. GPC1 exosome and its regulatory miRNAs are specific markers for the detection and target therapy of colorectal cancer. J Cell Mol Med. 2017 May; 21(5):838–847.
   Google Scholar
• Zhang H, Wang W, Fan S. The role of miRNAs in resistance to targeted treatments of non-small cell lung cancer. Cancer Chemother Pharmacol. 2017 Feb; 79(2):227–231.
   Google Scholar
• Di Leva G, Garofalo M, Croce CM MicroRNAs in cancer. Annu Rev Pathol. 2014;9:287–314. doi:10.1146/annurev-pathol-012513-10471524079833
   PubMed Web of Science ®Google Scholar
• Bai QL, Hu CW, Wang XR, et al. MiR-616 promotes proliferation and inhibits apoptosis in glioma cells by suppressing expression of SOX7 via the Wnt signaling pathway. Eur Rev Med Pharmacol Sci. 2017;21(24):5630–5637. doi:10.26355/eurrev_201712_1400629271996
   PubMed Web of Science ®Google Scholar
• Han L, Liu S, Liang J, et al. A genetic polymorphism at miR-526b binding-site in the lincRNA-NR_024015 exon confers risk of esophageal squamous cell carcinoma in a population of North China. Mol Carcinog. 2017;56(3):960–971. doi:10.1002/mc.2254927583835
   PubMed Web of Science ®Google Scholar
• Kim KH, Jung JY, Son ED, et al. miR-526b targets 3ʹ UTR of MMP1 mRNA. Exp Mol Med. 2015;47:e178. doi:10.1038/emm.2015.5226292968
   PubMed Web of Science ®Google Scholar
• Yang P, Wang Y, Peng X, et al. Management and survival rates in patients with glioma in China (2004–2010): a retrospective study from a single-institution. J Neurooncol. 2013;113(2):259–266. doi:10.1007/s11060-013-1103-923483435
   PubMed Web of Science ®Google Scholar
• Wick W, Weller M, van Den Bent M, et al. MGMT testing: the challenges for biomarker-based glioma treatment. Nat Rev Neurol. 2014;10(7):372–385. doi:10.1038/nrneurol.2014.10024912512
   PubMed Web of Science ®Google Scholar
• Peng G, Liao Y, Shen C.miRNA-429 Inhibits astrocytoma proliferation and invasion by targeting BMI1. Pathol Oncol Res. 2017 Apr;23(2):369. doi:10.1093/bja/aeu467376.
   Google Scholar
• Cohen AL, Colman H Glioma biology and molecular markers. Cancer Treat Res. 2015;163:15–30. doi:10.1007/978-3-319-12048-5_225468223
   PubMedGoogle Scholar
• Appin CL, Brat DJ Biomarker-driven diagnosis of diffuse gliomas. Mol Aspects Med. 2015;45:87–96. doi:10.1016/j.mam.2015.05.00226004297
   PubMed Web of Science ®Google Scholar
• Hayes J, Peruzzi PP, Lawler S MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med. 2014;20(8):460–469. doi:10.1016/j.molmed.2014.06.00525027972
   PubMed Web of Science ®Google Scholar
• Tutar Y miRNA and cancer: computational and experimental approaches. Curr Pharm Biotechnol. 2014;15(5):429. doi:10.2174/13892010150514082816133525189575
   PubMed Web of Science ®Google Scholar
• Liu X, Yang L, Tu J, et al. microRNA-526b servers as a prognostic factor and exhibits tumor suppressive property by targeting Sirtuin 7 in hepatocellular carcinoma. Oncotarget. 2017;8(50):87737–87749. doi:10.18632/oncotarget.2120929152116
   PubMedGoogle Scholar
• Zhang R, Zhao J, Xu J, et al. miR-526b-3p functions as a tumor suppressor in colon cancer by regulating HIF-1alpha. Am J Transl Res. 2016;8(6):2783–2789.27398161
   PubMed Web of Science ®Google Scholar
• Zhang ZY, Fu SL, Xu SQ, et al. By downregulating Ku80, hsa-miR-526b suppresses non-small cell lung cancer. Oncotarget. 2015;6(3):1462–1477. doi:10.18632/oncotarget.280825596743
   PubMedGoogle Scholar
• Do K, Doroshow JH, Kummar S Wee1 kinase as a target for cancer therapy. Cell Cycle. 2013;12(19):3159–3164. doi:10.4161/cc.2606224013427
   PubMed Web of Science ®Google Scholar
• Slipicevic A, Holth A, Hellesylt E, et al. Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions. Gynecol Oncol. 2014;135(1):118–124. doi:10.1016/j.ygyno.2014.07.10225093290
   PubMed Web of Science ®Google Scholar
• Brockway S, Zeleznik-Le NJ WEE1 is a validated target of the microRNA miR-17-92 cluster in leukemia. Cancer Genet. 2015;208(5):279–287. doi:10.1016/j.cancergen.2015.01.00125732734
   PubMed Web of Science ®Google Scholar
• Chang Q, Chandrashekhar M, Ketela T, et al. Cytokinetic effects of Wee1 disruption in pancreatic cancer. Cell Cycle. 2016;15(4):593–604. doi:10.1080/15384101.2016.113818826890070
   PubMed Web of Science ®Google Scholar
• Music D, Dahlrot RH, Hermansen SK, et al. Expression and prognostic value of the WEE1 kinase in gliomas. J Neurooncol. 2016;127(2):381–389. doi:10.1007/s11060-015-2050-426738845
   PubMed Web of Science ®Google Scholar
• Caretti V, Hiddingh L, Lagerweij T, et al. WEE1 kinase inhibition enhances the radiation response of diffuse intrinsic pontine gliomas. Mol Cancer Ther. 2013;12(2):141–150. doi:10.1158/1535-7163.MCT-12-073523270927
   PubMed Web of Science ®Google Scholar